| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AEGLEA BIOTHERAPEUTICS INC | 6,000 | 29,000 | 0.03% | ||
| 2 | Sierra Oncology, Inc. | 56,056 | 112,000 | 0.12% | ||
| 3 | REGENXBIO INC COM | 52,500 | 420,000 | 0.44% | ||
| 4 | CYTOMX THERAPEUTICS INC COM | 64,200 | 656,000 | 0.68% | ||
| 5 | STEMLINE THERAPEUTICS INC | 135,420 | 917,000 | 0.95% | ||
| 6 | Ascendis Pharma | 90,000 | 1,194,000 | 1.24% | ||
| 7 | GLOBAL BLOOD THERAPEUTICS INCORPORATED | 72,990 | 1,211,000 | 1.25% | ||
| 8 | ARCA biopharma Inc | 462,399 | 1,341,000 | 1.39% | ||
| 9 | EDGE THERAPEUTICS INC | 135,000 | 1,365,000 | 1.41% | ||
| 10 | OCERA THERAPEUTICS INC | 796,550 | 1,513,000 | 1.57% | ||
| 11 | BEIGENE LTD | 51,000 | 1,520,000 | 1.58% | ||
| 12 | Cynapsus Therapeutics Inc | 108,575 | 1,806,000 | 1.87% | ||
| 13 | AKARI THERAPEUTICS PLC | 158,352 | 2,136,000 | 2.21% | ||
| 14 | Axovant Sciences LTD | 184,110 | 2,364,000 | 2.45% | ||
| 15 | LIPOCINE INC NEW | 849,921 | 2,584,000 | 2.68% | ||
| 16 | ALCOBRA LTD | 623,313 | 2,799,000 | 2.90% | ||
| 17 | BIOCRYST PHARMACEUTICALS | 1,005,104 | 2,854,000 | 2.96% | ||
| 18 | ADVERUM BIOTECHNOLOGIES INC | 1,102,735 | 3,485,000 | 3.61% | ||
| 19 | ZAFGEN INC COM | 602,114 | 3,607,000 | 3.74% | ||
| 20 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 5,370,000 | 5.57% | ||
| 21 | COHERUS BIOSCIENCES INC COM | 611,010 | 10,320,000 | 10.69% | ||
| 22 | HERON THERAPEUTICS INC COM | 1,095,734 | 19,778,000 | 20.50% | ||
| 23 | DBV Technologies | 456,893 | 29,114,000 | 30.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019779, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
